Literature DB >> 23991944

Physical activity and its relation to cancer risk: updating the evidence.

Joanna Kruk1, Urszula Czerniak.   

Abstract

Scientific evidence for the primary prevention of cancer caused by physical activity of regular moderate-intensity or greater is rapidly accumulating in this field. About 300 epidemiologic studies on the association between physical activity and cancer risk have been conducted worldwide. The objectives of this paper were three-fold: (i) to describe briefly the components of physical activity and its quantification; (ii) to summarize the most important conclusions available from comprehensive reports, and reviews of the epidemiologic individual and intervention studies on a role physical activity in cancer prevention; (iii) to present proposed biological mechanisms accounting for effects of activity on cancer risk. The evidence of causal linked physical activity and cancer risk is found to be strong for colon cancer - convincing; weaker for postmenopausal breast and endometrium cancers - probable; and limited suggestive for premenopausal breast, lung, prostate, ovary, gastric and pancreatic cancers. The average risk reductions were reported to be 20-30%. The protective effects of physical activity on cancer risk are hypothesized to be through multiple interrelated pathways: decrease in adiposity, decrease in sexual and metabolic hormones, changes in biomarkers and insulin resistance, improvement of immune function, and reduction of inflammation. As there are several gaps in the literature for associations between activity and cancer risk, additional studies are needed. Future research should include studies dealing with limitations in precise estimates of physical activity and of a lack of consensus on what defines sedentary behavior of individuals and those linked with the proposed biomarkers to cancer risk and controlled exercise intervention trials.

Entities:  

Mesh:

Year:  2013        PMID: 23991944     DOI: 10.7314/apjcp.2013.14.7.3993

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  36 in total

1.  Impact of Physical Inactivity on Risk of Developing Cancer of the Uterine Cervix: A Case-Control Study.

Authors:  James Brian Szender; Rikki Cannioto; Nicolas R Gulati; Kristina L Schmitt; Grace Friel; Albina Minlikeeva; Alexis Platek; Emily H Gower; Ryan Nagy; Edgar Khachatryan; Paul C Mayor; Karin A Kasza; Shashikant B Lele; Kunle Odunsi; Kirsten B Moysich
Journal:  J Low Genit Tract Dis       Date:  2016-07       Impact factor: 1.925

Review 2.  Epithelial ovarian cancer and recreational physical activity: A review of the epidemiological literature and implications for exercise prescription.

Authors:  Rikki A Cannioto; Kirsten B Moysich
Journal:  Gynecol Oncol       Date:  2015-03-20       Impact factor: 5.482

Review 3.  Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms.

Authors:  Frank W Booth; Christian K Roberts; John P Thyfault; Gregory N Ruegsegger; Ryan G Toedebusch
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

4.  The association of lifetime physical inactivity with head and neck cancer: a hospital-based case-control analysis.

Authors:  Alexis J Platek; Rikki A Cannioto; John Lewis Etter; Jae Kim; Janine M Joseph; Nicholas R Gulati; Kristina L Schmitt; Emily Callahan; Edgar Khachatryan; Ryan Nagy; Albina Minlikeeva; J Brian Szender; Anurag K Singh; Iris Danziger; Kirsten B Moysich
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-08-05       Impact factor: 2.503

Review 5.  Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.

Authors:  Rikki Cannioto; Michael J LaMonte; Harvey A Risch; Chi-Chen Hong; Lara E Sucheston-Campbell; Kevin H Eng; J Brian Szender; Jenny Chang-Claude; Barbara Schmalfeldt; Ruediger Klapdor; Emily Gower; Albina N Minlikeeva; Gary R Zirpoli; Elisa V Bandera; Andrew Berchuck; Daniel Cramer; Jennifer A Doherty; Robert P Edwards; Brooke L Fridley; Ellen L Goode; Marc T Goodman; Estrid Hogdall; Satoyo Hosono; Allan Jensen; Susan Jordan; Susanne K Kjaer; Keitaro Matsuo; Roberta B Ness; Catherine M Olsen; Sara H Olson; Celeste Leigh Pearce; Malcolm C Pike; Mary Anne Rossing; Elizabeth A Szamreta; Pamela J Thompson; Chiu-Chen Tseng; Robert A Vierkant; Penelope M Webb; Nicolas Wentzensen; Kristine G Wicklund; Stacey J Winham; Anna H Wu; Francesmary Modugno; Joellen M Schildkraut; Kathryn L Terry; Linda E Kelemen; Kirsten B Moysich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-06       Impact factor: 4.254

6.  Nonoccupational physical activity and risk of ovarian cancer: a meta-analysis.

Authors:  Shanliang Zhong; Lin Chen; Mengmeng Lv; Tengfei Ma; Xiaohui Zhang; Jianhua Zhao
Journal:  Tumour Biol       Date:  2014-08-06

7.  Physical health composite and risk of cancer mortality in the REasons for Geographic and Racial Differences in Stroke Study.

Authors:  Justin Xavier Moore; Stephen J Carter; Victoria Williams; Saira Khan; Marquita W Lewis-Thames; Keon Gilbert; George Howard
Journal:  Prev Med       Date:  2020-01-16       Impact factor: 4.018

Review 8.  Current Evidence of the Role of the Myokine Irisin in Cancer.

Authors:  Evangelia Tsiani; Nicole Tsakiridis; Rozalia Kouvelioti; Alina Jaglanian; Panagiota Klentrou
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

9.  Description of Lifestyle, Including Social Life, Diet and Physical Activity, of People ≥90 years Living in Ikaria, a Longevity Blue Zone.

Authors:  Romain Legrand; Gilles Nuemi; Michel Poulain; Patrick Manckoundia
Journal:  Int J Environ Res Public Health       Date:  2021-06-19       Impact factor: 3.390

10.  NOTCH Single Nucleotide Polymorphisms in the Predisposition of Breast and Colorectal Cancers in Saudi Patients.

Authors:  Ibrahim O Alanazi; Jilani Purusottapatnam Shaik; Narasimha Reddy Parine; Abdulrahman Al Naeem; Nahla A Azzam; Majid A Almadi; Abdulrahman M Aljebreen; Othman Alharbi; Mohammad Saud Alanazi; Zahid Khan
Journal:  Pathol Oncol Res       Date:  2021-04-09       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.